Table 3.
Comparison of Patients with and Without OSA
| OSA (+) | OSA (−) | P | |
|---|---|---|---|
| M/F | 9/15 | 6/13 | .76 |
| Age (years) (mean ± SD) | 58 ± 13 | 45 ± 15 | .01 |
| Duration of disease (years) (mean ± SD) | 37.3 ± 19.8 | 23.7 ± 15.2 | .03 |
| BMI (kg/m2) (mean ± SD) | 26.8 ± 5.4 | 25.4 ± 5.9 | .93 |
| FVC (%) (mean ± SD) | 78 ± 21 | 80 ± 19 | .633 |
| FEV1 (%) (mean ± SD) | 64 ± 26 | 65 ± 22 | .760 |
| FEV1/FVC (mean ± SD) | 66 ± 14 | 67 ± 14 | .816 |
| Obstruction, n (%) | 15 (62.5) | 14 (73.7) | .523 |
| Restriction, n (%) | 11 (45.8) | 8 (42.1) | 1.000 |
| Main complaints, n (%) | 21 (87) | 16 (84) | .3 |
| Snoring | 18(75) | 12(63.1) | .82 |
| Witnessed apnea | 8(33.3) | 3(15.7) | .01 |
| Excessive daytime sleepiness | 19(79.1) | 13(68.4) | .33 |
| Colonization, n (%) | 11 (45.8) | 5 (26.3) | .161 |
| Bronchiectasis localization, n (%) | |||
| Upper lobe | 11 (45.8) | 9 (47.4) | 1.000 |
| Lower lobe | 14 (58.3) | 15 (78.9) | .325 |
| Number of lobes with bronchiectasis, n (mean ± SD) | 2.3 ± 1.7 | 2.4 ± 1.3 | .624 |
| Type of bronchiectasis, n (%) | |||
| Cystic | 4 (16.6) | 8 (42.1) | .08 |
| Cylindrical | 10 (41.6) | 7 (36.8) | .96 |
| Varicose | 3 (13.0) | 4 (21.0) | .51 |
| Traction | 4 (16.6) | 1 (5.3) | .12 |
| Epworth score (mean ± SD) | 6.1 ± 4.9 | 6.6 ± 4.4 | .50 |
| Stage 1 (%) (mean ± SD) | 7.8 ± 4.3 | 6.3 ± 4.8 | .12 |
| Stage 2 (%) (mean ± SD) | 53.0 ± 12.0 | 58.6 ± 16.1 | .31 |
| Stage 3 (%) (mean ± SD) | 22.2 ± 13.9 | 21.2 ± 10.4 | .81 |
| REM (%) (mean ± SD) | 16.8 ± 8.5 | 11.8 ± 5.0 | .03 |
BMI, body mass index; F, female; FVC, forced vital capacity; M, male; REM, rapid eye movement; SD, standard deviation.